MedTrace Logo

Clinical Assessment of an in-Patient Glucose Monitoring System (Accu-Chek Inform Cobas IT 1000)

NCT00486681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 949

Last updated 2008-03-04

No results posted yet for this study

Summary

The principal objective of this single-center 2-period study is to evaluate the glycemic control of in-patients in 3 hospital departments (Diabetology, Cardiology and Pulmonary Care) as the rate of capillary blood glucose measurements within a pre-define target range, and to compare results during the period I (warning of the Accu-Check Inform glucose meter on glucose levels not activated) and period II (warning activated).

Conditions

Interventions

DEVICE

Accu Chek Inform and Cobas IT 1000

period II (warning activated)

Sponsors & Collaborators

  • Roche Diagnostics Meylan France

    collaborator UNKNOWN

  • Assistance Medico-Technique A Domicile

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • NELLY WION, MD · University Hospital, Grenoble

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2007-07-31
Completion
2008-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00486681 on ClinicalTrials.gov